Biologics is radically changing the way we treat many devastating diseases. Equip your business today to succeed in this exciting and rapidly expanding field.
Revolutionizing the way we treat several serious disorders, the field of biologics has provided a better outcome for patients across the globe, many with diseases that previously had no therapeutic alternatives.
Driven by continuing advancements in technology, biologics product development has risen rapidly in recent years, with the market forecast to double by 2030. These complex therapeutics have galvanized the life sciences space, providing cutting edge treatment options in oncology, immune conditions and rare diseases.
We work with our extensive network of partners and key opinion leaders to facilitate professional support across all manner of biologicals and vaccines, including:
Human vaccines including mRNA | bacterial and viral products | monoclonal antibodies | recombinant proteins | allergy products | immunotherapy in oncology
From acquisitions to operations, the experienced core team and global network of advisors at PharmaBioSource has a wealth of experience advising on:
- Sale, Lease and Purchase of Laboratory and Manufacturing Facilities
- Therapeutic Asset Scouting
- Carve Outs and Divestments
- Corporate M&A Transactions
- Cost of Goods Modeling
- Investment Diligence
- Manufacturing Capacity Evaluation
- CMO/CDMO Sourcing and Evaluation
